CBIZ Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CBIZ in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CBIZ stock.
View analyst ratings for CBIZ or view top-rated stocks.

CBIZ's stock was trading at $39.12 at the beginning of the year. Since then, CBZ stock has increased by 2.5% and is now trading at $40.09.
View the best growth stocks for 2022 here.

CBIZ saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 851,300 shares, an increase of 34.9% from the May 31st total of 630,900 shares. Based on an average daily trading volume, of 240,400 shares, the short-interest ratio is currently 3.5 days. Currently, 1.7% of the company's shares are sold short.
View CBIZ's Short Interest.

CBIZ is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for CBIZ.

CBIZ, Inc. (NYSE:CBZ) posted its earnings results on Thursday, April, 28th. The business services provider reported $1.18 EPS for the quarter, beating analysts' consensus estimates of $1.03 by $0.15. The business services provider had revenue of $391.70 million for the quarter, compared to analyst estimates of $367.46 million. CBIZ had a net margin of 6.59% and a trailing twelve-month return on equity of 14.06%. The company's revenue was up 30.3% compared to the same quarter last year. During the same period last year, the firm earned $0.92 EPS.
View CBIZ's earnings history.

CBIZ updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of $1.99-$2.03 for the period, compared to the consensus EPS estimate of $1.97. The company issued revenue guidance of $1.31 billion-$1.34 billion, compared to the consensus revenue estimate of $1.30 billion.

57 employees have rated CBIZ CEO Jerry Grisko on Glassdoor.com. Jerry Grisko has an approval rating of 84% among CBIZ's employees.

Some companies that are related to CBIZ include Verisk Analytics (VRSK), Equifax (EFX), Nielsen (NLSN), FTI Consulting (FCN), Dun & Bradstreet (DNB), Exponent (EXPO), ICF International (ICFI), Huron Consulting Group (HURN), Franklin Covey (FC), CRA International (CRAI), VSE (VSEC), Acacia Research (ACTG), Mistras Group (MG) and Odyssey Marine Exploration (OMEX).
View all of CBZ's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other CBIZ investors own include Walt Disney (DIS), Veracyte (VCYT), Carnival Co. & (CCL), CRISPR Therapeutics (CRSP), Etsy (ETSY), Gilead Sciences (GILD), Johnson & Johnson (JNJ), KeyCorp (KEY), Altria Group (MO) and NeoGenomics (NEO).

CBIZ trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBZ."

Shares of CBZ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CBZ stock can currently be purchased for approximately $40.09.

CBIZ (NYSE:CBZ) has a market capitalization of $2.09 billion and generates $1.10 billion in revenue each year. The business services provider earns $70.89 million in net income (profit) each year or $1.48 on an earnings per share basis.

CBIZ employs 6,000 workers across the globe.

CBIZ's mailing address is 6050 OAK TREE BOULEVARD SOUTH SUITE 500, CLEVELAND OH, 44131. The official website for CBIZ is www.cbiz.com. The business services provider can be reached via phone at (216) 447-9000 or via fax at 216-447-9007.